These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1643641)

  • 21. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
    Göckler N; Jofre G; Papadopoulos C; Soppa U; Tejedor FJ; Becker W
    FEBS J; 2009 Nov; 276(21):6324-37. PubMed ID: 19796173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
    Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
    Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
    Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
    Puttini M; Redaelli S; Moretti L; Brussolo S; Gunby RH; Mologni L; Marchesi E; Cleris L; Donella-Deana A; Drueckes P; Sala E; Lucchini V; Kubbutat M; Formelli F; Zambon A; Scapozza L; Gambacorti-Passerini C
    Haematologica; 2008 May; 93(5):653-61. PubMed ID: 18367480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine kinase modulation of protein kinase C activity regulates G protein-linked Ca2+ signaling in leukemic hematopoietic cells.
    Vichalkovski A; Kotevic I; Gebhardt N; Kaderli R; Porzig H
    Cell Calcium; 2006 Jun; 39(6):517-28. PubMed ID: 16620963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.
    Griffin RJ; Fontana G; Golding BT; Guiard S; Hardcastle IR; Leahy JJ; Martin N; Richardson C; Rigoreau L; Stockley M; Smith GC
    J Med Chem; 2005 Jan; 48(2):569-85. PubMed ID: 15658870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
    Davis RL; Konopka JB; Witte ON
    Mol Cell Biol; 1985 Jan; 5(1):204-13. PubMed ID: 4039028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors.
    Geissler JF; Traxler P; Regenass U; Murray BJ; Roesel JL; Meyer T; McGlynn E; Storni A; Lydon NB
    J Biol Chem; 1990 Dec; 265(36):22255-61. PubMed ID: 2176210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase.
    Traxler PM; Wacker O; Bach HL; Geissler JF; Kump W; Meyer T; Regenass U; Roesel JL; Lydon N
    J Med Chem; 1991 Aug; 34(8):2328-37. PubMed ID: 1652014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.
    Cassinelli G; Lanzi C; Pensa T; Gambetta RA; Nasini G; Cuccuru G; Cassinis M; Pratesi G; Polizzi D; Tortoreto M; Zunino F
    Biochem Pharmacol; 2000 Jun; 59(12):1539-47. PubMed ID: 10799650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.
    Konopka JB; Davis RL; Watanabe SM; Ponticelli AS; Schiff-Maker L; Rosenberg N; Witte ON
    J Virol; 1984 Jul; 51(1):223-32. PubMed ID: 6610061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.
    Kruse CH; Holden KG; Pritchard ML; Feild JA; Rieman DJ; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1762-7. PubMed ID: 2970550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
    Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
    Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases.
    Hagiwara M; Inoue S; Tanaka T; Nunoki K; Ito M; Hidaka H
    Biochem Pharmacol; 1988 Aug; 37(15):2987-92. PubMed ID: 3164998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2.
    Kruse CH; Holden KG; Offen PH; Pritchard ML; Feild JA; Rieman DJ; Bender PE; Ferguson B; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1768-72. PubMed ID: 3045321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective repression of v-abl-encoded protein by N-methylisatin-beta-4',4'-diethylthiosemicarbazone and N-allylisatin-beta-4',4'-diallylthiosemicarbazone.
    Teitz Y; Ladizensky E; Barko N; Burstein E
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2483-5. PubMed ID: 8285639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.
    Palmer BD; Rewcastle GW; Thompson AM; Boyd M; Showalter HD; Sercel AD; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1995 Jan; 38(1):58-67. PubMed ID: 7837241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.